These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 11281499

  • 1. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S, Limpaphayom KK.
    J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK, Bunyavejchevin S.
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [Abstract] [Full Text] [Related]

  • 3. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 4. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 5. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial.
    Liu JH, Muse KN.
    Am J Obstet Gynecol; 2005 Apr; 192(4):1316-23; discussion 1323-4. PubMed ID: 15846228
    [Abstract] [Full Text] [Related]

  • 6. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW, Gluck OS, Lang E, Rakov V.
    Menopause; 2005 Apr; 12(6):741-8. PubMed ID: 16278618
    [Abstract] [Full Text] [Related]

  • 7. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 8. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.
    Chin Med J (Engl); 2004 Jul 15; 117(7):1029-35. PubMed ID: 15265377
    [Abstract] [Full Text] [Related]

  • 9. A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women.
    Cigler T, Tu D, Yaffe MJ, Findlay B, Verma S, Johnston D, Richardson H, Hu H, Qi S, Goss PE.
    Breast Cancer Res Treat; 2010 Apr 15; 120(2):427-35. PubMed ID: 19967558
    [Abstract] [Full Text] [Related]

  • 10. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P.
    Menopause; 2003 Apr 15; 10(6):550-8. PubMed ID: 14627865
    [Abstract] [Full Text] [Related]

  • 11. Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women.
    Rejnmark L, Buus NH, Vestergaard P, Heickendorff L, Andreasen F, Larsen ML, Mosekilde L.
    J Bone Miner Res; 2004 May 15; 19(5):737-44. PubMed ID: 15068496
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 15; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 13. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harpe K.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):269-73. PubMed ID: 15059505
    [Abstract] [Full Text] [Related]

  • 14. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.
    Zhang G, Qin L, Shi Y.
    J Bone Miner Res; 2007 Jul 17; 22(7):1072-9. PubMed ID: 17419678
    [Abstract] [Full Text] [Related]

  • 15. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE, Bjarnason NH, Neven P, Plouffe L, Johnston CC, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.
    Menopause; 2003 Jul 17; 10(4):337-44. PubMed ID: 12851517
    [Abstract] [Full Text] [Related]

  • 16. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.
    Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, Vittinghoff E, Grady D.
    Obstet Gynecol; 2004 Sep 17; 104(3):443-51. PubMed ID: 15339752
    [Abstract] [Full Text] [Related]

  • 17. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 17; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 18. Intranasal continuous combined 17 beta-estradiol/norethisterone therapy improves the lipid profile in healthy postmenopausal women.
    Hemelaar M, Kenemans P, de Bie L, van de Weijer PH, van der Mooren MJ.
    Fertil Steril; 2006 Apr 17; 85(4):979-88. PubMed ID: 16580384
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR, Eastell R, Fogelman I, Adachi JD, Rosen A, Netelenbos C, Watts NB, Seeman E, Ciaccia AV, Draper MW.
    Arch Intern Med; 2004 Apr 26; 164(8):871-9. PubMed ID: 15111373
    [Abstract] [Full Text] [Related]

  • 20. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.
    Curr Med Res Opin; 2007 Jun 26; 23(6):1341-9. PubMed ID: 17594775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.